Ascend Capital’s Intuitive Surgical ISRG Stock Holding History

Ascend Capital’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-90,840	Closed	-$11.1M	–	236
2017 Q4	$11.1M	Buy	+90,840	New	+$11.4M	0.42%	72

Other funds holding ISRG

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ascend Capital's ISRG Position: Q1 2018 in Review

Ascend Capital sold out of Intuitive Surgical (ISRG) in Q1 2018, closing a stake of 90,840 shares — an estimated $11.1M sold.

Ascend Capital first reported a position in ISRG in Q4 2017 and held it in 1 quarter. The position peaked at $11.1M in Q4 2017. 790 funds tracked by Wall St. Rank hold ISRG as of Q1 2018.

Ascend Capital reported no remaining Intuitive Surgical position as of Q1 2018 after selling out during the quarter.
Ascend Capital sold 90,840 Intuitive Surgical shares in Q1 2018, an estimated $11.1M.
Ascend Capital first reported a position in Intuitive Surgical in Q4 2017 and held it in 1 quarter.
Ascend Capital's Intuitive Surgical position peaked at $11.1M in Q4 2017.
790 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2018.

Based on Ascend Capital's 13F filing for Q1 2018, filed 14 May 2018.